Alliance Global Partners initiated coverage of Itamar Medical (NASDAQ:ITMR) with a “buy” rating and $15.50 price target. The stock closed at $9.10 on Aug. 29. “We see Itamar as the technology leader in home sleep...
In a new report, Alliance Global Partners analyst Ben Haynor writes that investors appear to have ignored the potential of Profound Medical’s (OTCQX:PRFMF; TSX:PRN) TULSA-PRO MRI-guided ablation system for the treatment...
By Len Zehr As a senior research analyst with Feltl & Co. for the past six years, Ben Haynor ranked second in the May 2013 Wall Street Journal Best on the Street publication in the Medical Equipment and Supplies...